Literature DB >> 8071830

In vitro drug release behavior of D,L-lactide/glycolide copolymer (PLGA) nanospheres with nafarelin acetate prepared by a novel spontaneous emulsification solvent diffusion method.

T Niwa1, H Takeuchi, T Hino, N Kunou, Y Kawashima.   

Abstract

Nanospheres with D,L-lactide/glycolide copolymer (PLGA) were prepared as a biodegradable and biocompatible polymeric carrier for peptide drugs by a novel spontaneous emulsification solvent diffusion method. Nafarelin acetate (NA), a luteinizing hormone-releasing hormone analogue, was employed as a model peptide drug to investigate the encapsulation efficiency. The drug and PLGA, dissolved in an acetone-dichloromethane-water mixture, were poured into an aqueous solution of polyvinyl alcohol under moderate stirring at room temperature. Spontaneous emulsification arising from a rapid diffusion of acetone from the organic to the aqueous phase enables preparation of PLGA submicron spheres 200-300 nm in size. The entrapment of NA in nanospheres was improved by blending low molecular weight (Mw = 4500) PLGA with higher molecular weight PLGA due to the synergistic effect of the rapid deposition of PLGA and the ionic interaction between NA and PLGA. By coadmixing a small amount of negatively charged phospholipids such as dipalmitoyl phosphatidylglycerol or dicetyl phosphate, the leakage of water-soluble NA was further prevented. The NA encapsulated in PLGA nanospheres was more stable than native NA in acidic medium (pH = 1.2). The drug-release behavior from nanospheres suspended in the disintegration test solution no. 1 (Japanese Pharmacopeia XII) exhibited a biphasic pattern. It was found tht the initial burst of release might be due to the degradation of the PLGA chain, as monitored by gel permeation chromatography. At a later stage, the drug was released more slowly, the rate of which was determined by the diffusion of the drug in the porous matrix structure.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8071830     DOI: 10.1002/jps.2600830527

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  15 in total

1.  Microsphere preparation using the untoxic solvent glycofurol.

Authors:  Daniela Allhenn; Alf Lamprecht
Journal:  Pharm Res       Date:  2010-10-29       Impact factor: 4.200

2.  Particle size and temperature effect on the physical stability of PLGA nanospheres and microspheres containing Bodipy.

Authors:  Sinjan De; Dennis H Robinson
Journal:  AAPS PharmSciTech       Date:  2004-09-13       Impact factor: 3.246

Review 3.  Drug transport to brain with targeted nanoparticles.

Authors:  Jean-Christophe Olivier
Journal:  NeuroRx       Date:  2005-01

4.  (-)-Hinokinin-loaded poly(D,-lactide-co-glycolide) microparticles for Chagas disease.

Authors:  Juliana Saraiva; Ana Amélia Moreira Lira; Viviane Rodrigues Esperandim; Daniele da Silva Ferreira; Antônio Sérgio Ferraudo; Jairo Kenupp Bastos; Márcio Luís Andrade E Silva; Cristiane Masetto de Gaitani; Sérgio de Albuquerque; Juliana Maldonado Marchetti
Journal:  Parasitol Res       Date:  2010-01-28       Impact factor: 2.289

Review 5.  Applications of the ion-pair concept to hydrophilic substances with special emphasis on peptides.

Authors:  D Quintanar-Guerrero; E Allémann; H Fessi; E Doelker
Journal:  Pharm Res       Date:  1997-02       Impact factor: 4.200

6.  Effect of polymer blending on the release of ganciclovir from PLGA microspheres.

Authors:  Sridhar Duvvuri; Kumar Gaurav Janoria; Ashim K Mitra
Journal:  Pharm Res       Date:  2006-12-06       Impact factor: 4.200

7.  Aerosol Delivery of siRNA to the Lungs. Part 2: Nanocarrier-based Delivery Systems.

Authors:  Susanne R Youngren-Ortiz; Nishant S Gandhi; Laura España-Serrano; Mahavir B Chougule
Journal:  Kona       Date:  2016-04-30       Impact factor: 2.897

8.  Promising bioadhesive ofloxacin-loaded polymeric nanoparticles for the treatment of ocular inflammation: formulation and in vivo evaluation.

Authors:  Alaa H Salama; Mona M AbouSamra; Ghada E A Awad; Soheir S Mansy
Journal:  Drug Deliv Transl Res       Date:  2020-10-02       Impact factor: 4.617

9.  Process variable implications for residual solvent removal and polymer morphology in the formation of gentamycin-loaded poly (L-lactide) microparticles.

Authors:  R F Falk; T W Randolph
Journal:  Pharm Res       Date:  1998-08       Impact factor: 4.200

10.  Influence of selected formulation variables on the preparation of enzyme-entrapped Eudragit S100 microspheres.

Authors:  Manju Rawat; Shailendra Saraf; Swarnlata Saraf
Journal:  AAPS PharmSciTech       Date:  2007-12-28       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.